jasjas1973
The Pharma Industry is making plans to ensure up to 6/10 weeks supply yes?
It's 14-18 weeks for Insulin - which is the only I've seen confirmed.
The Government have contracted supply routes for at least 6 months away from Dover:
Securing, via the Department of Transport (DfT), additional roll on, roll off freight capacity (away from the short straits) from 29 March.
Contracts have been signed by DfT with two ferry companies for the next six months. These routes are away from the Dover Straits where most goods flow from the EU and will run from the following routes: Cherbourg–Poole, Le Havre–Portsmouth, Roscoff–Plymouth, Caen – Portsmouth, Vlaardingen–Immingham, Cuxhaven–Immingham and Vlaardingen–Felixstowe. The Government has purchased the tickets from the shipping freight operators, and these will be sold on at market rate.
There is cross Government agreement that all medicines and medical products will be prioritised on these alternative routes to ensure the flow of all these products may continue unimpeded.
We have worked with the pharmaceutical industry to ensure that planes are contracted to bring in medical radioisotopes under the appropriate specialist conditions.
Also: making changes to, or clarifications of, certain regulatory requirements so that companies can continue to sell their products in the UK even if we have no deal.The MHRA has for this scenario consulted on, and published, further guidance on how medicines, medical devices and clinical trials will be regulated.
Just spotted this -
www.independent.co.uk/news/uk/politics/brexit-theresa-may-european-agencies-medicine-chemical-aerospace-uk-pay-remain-a8236916.html
Theresa May reveals UK willing to pay to remain part of European agencies for medicine, chemicals and aviation
PM says she would seek ‘associate membership’ of the bodies in the negotiations with Brussels.
Responding to the Prime Minister’s speech, Dr Andrew Dearden, the British Medical Association (BMA) treasurer, welcomed the decision to explore associate membership of the medicines agency.
He added:“The EMA helps the UK with timely and safe access to medicines, and likewise helps the EU access medicines that are developed here in the UK. We want to see the Government work closely with the EMA through a formal agreement to continue to support and participate in their assessments for medicines approvals.”
The Association of the British Pharmaceutical Industry (ABPI)–a body representing pharmaceutical companies in the UK–added that every month, 45 million packs of medicine move from the UK to the EU and 37 million come the other way.
“That is why the Prime Minister’s commitment to seek cooperation on medicines regulation would be the best outcome for patients, not just in the UK but across Europe,”